Evidence map›Paper›PMID 31665781›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Occurrence of Typhoid Fever Complications and Their Relation to Duration of Illness Preceding Hospitalization: A Systematic Literature Review and Meta-analysis.

Ligia María Cruz Espinoza, Ellen McCreedy, Marianne Holm, Justin Im, Ondari D Mogeni, Prerana Parajulee, Ursula Panzner, Se Eun Park, Trevor Toy, Andrea Haselbeck and 7 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Typhoid conjugate vaccines for preventing typhoid fever (enteric fever).The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Trial
  3. Article
  4. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Typhoid fever.Nature reviews. Disease primers · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 4 countries.

Ligia María Cruz EspinozaInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ellen McCreedyCenter for Gerontology and Healthcare Research, School of Public Health, Brown University, Providence, Rhode Island.
Marianne HolmInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Justin ImInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ondari D MogeniInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Prerana ParajuleeInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ursula PanznerInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Se Eun ParkInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Trevor ToyInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Andrea HaselbeckInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Hye Jin SeoInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Hyon Jin JeonInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Jong-Hoon KimInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Soo Young KwonInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Jerome H KimInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Christopher M ParryClinical Sciences, Liverpool School of Tropical Medicine, United Kingdom.
Florian MarksInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
International Vaccine Institute · KRBrown University · USLiverpool School of Tropical Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComplications from typhoid fever disease have been estimated to occur in 10%-15% of hospitalized patients, with evidence of a higher risk in children and when delaying the implementation of effective antimicrobial treatment. We estimated the prevalence of complications in hospitalized patients with culture-confirmed typhoid fever and the effects of delaying the implementation of effective antimicrobial treatment and age on the prevalence and risk of complications.

methodsA systematic review and meta-analysis were performed using studies in the PubMed database. We rated risk of bias and conducted random-effects meta-analyses. Days of disease at hospitalization (DDA) was used as a surrogate for delaying the implementation of effective antimicrobial treatment. Analyses were stratified by DDA (DDA <10 versus ≥10 mean/median days of disease) and by age (children versus adults). Differences in risk were assessed using odds ratios (ORs) and 95% confidence intervals (CIs). Heterogeneity and publication bias were evaluated with the I2 value and funnel plot analysis, respectively.

resultsThe pooled prevalence of complications estimated among hospitalized typhoid fever patients was 27% (95% CI, 21%-32%; I2 = 90.9%, P < .0001). Patients with a DDA ≥ 10 days presented higher prevalence (36% [95% CI, 29%-43%]) and three times greater risk of severe disease (OR, 3.00 [95% CI, 2.14-4.17]; P < .0001) than patients arriving earlier (16% [95% CI, 13%- 18%]). Difference in prevalence and risk by age groups were not significant.

conclusionsThis meta-analysis identified a higher overall prevalence of complications than previously reported and a strong association between duration of symptoms prior to hospitalization and risk of serious complications.

Indexed as

AdultAnti-Bacterial AgentsChildCross-Sectional StudiesHospitalizationHumansPrevalenceProspective StudiesRetrospective StudiesRisk FactorsTyphoid FeverAnti-Bacterial Agentscomplicationsmeta-analysisprevalencerisk factorstyphoid fever

Identifiers

PMID31665781
PMCPMC6821330
OpenAlexW2982602544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.